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and one unpleasant (rotten eggs), were delivered using an olfactom-
eter (OM6b; Burghart instruments, Wedel, Germany). Olfactory 
stimuli were applied during fMRI scanning to study disease-related 
modulation of central nervous system structures and to advance 
our understanding of olfactory dysfunction in PD patients.
Materials and Methods
subjects
Only women were included in order to control for possible sex-
related differences in olfactory abilities. We investigated 11 patients 
with Parkinson’s disease (mean age 60 ± 10.9 years) and 13 age 
matched controls (mean age 58 ± 9.6 years). However, three PD 
patients had to be excluded from the study because they failed to 
cooperate throughout the entire scanning session. PD duration 
ranged from 1 to 9 years (mean 6.63 years). Patients presented with 
a mean “Unified Parkinson’s Disease Rating Scale III” (UPDRS 
III) (Fahn and Elton, 1987) score of 23.3 (range, 6–46). United 
Kingdom Parkinson’s Disease Society Brain Bank Diagnostic 
Criteria for Parkinson’s Disease (Daniel and Lees, 1993) were 
applied for all patients. None of the control subjects had a his-
tory of neurological or psychiatric disease and all subjects were 
non-smokers. Apart from one PD patient none of the participants 
exhibited signs of major depression (Beck Depression Inventory, 
Beck et al., 1961; Hautzinger et al., 1995, BDI score ≥ 15). The study 
was approved by the local ethics committee and all subjects gave 
written informed consent.
introduction
There is convincing evidence from numerous studies using both psy-
chophysical (Ramaker et al., 2002; Litvan et al., 2003) and electrophysi-
ological approaches (Hummel et al., 1993; Barz et al., 1997; Hawkes 
and Shephard, 1998) that olfaction is markedly reduced in idiopathic 
Parkinson’s disease (PD). The decreased olfactory function precedes 
the onset of motor symptoms by approximately 4 years (Berendse 
and Ponsen, 2006; Haehner et al., 2007); it appears independent of 
the medication used and does not respond to changes in medication 
(Doty et al., 1988). Thus, although hyposmia has already become a 
useful diagnostic criterium for the presence of idiopathic PD (Doty 
et al., 1995; Hummel et al., 2010), little is known, however, whether 
and how the pattern of olfactory activation differs in PD compared to 
healthy individuals. Westermann et al. (2008) suggested that selective 
impairment of amygdala and hippocampal activation contributes to 
olfactory dysfunction in PD. In a functional magnetic resonance imag-
ing (fMRI) study (Westermann et al., 2008), they observed a mainly 
lateralized activation pattern in PD and discussed the involvement 
of compensatory mechanisms in the olfactory deficit. In that study, 
only the pleasant rose-like odor PEA was used for olfactory stimula-
tion which may have biased the pattern of activation. In fact, it is still 
an open question whether affective experience modulates olfactory 
activation in individuals with smell dysfunction.
The issue of hedonic-specific activation was addressed in this 
investigation. We performed fMRI in PD patients and healthy con-
trols while two specific olfactory stimuli, one pleasant (rose-like) 
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olfactory testing
All participants underwent a standardized psychophysical olfac-
tory test, the “Sniffin’ Sticks” (Hummel et al., 1997). Odorants were 
presented in pen-like odor dispensing devices. For odor presenta-
tion the pen’s cap was removed by the experimenter for approxi-
mately 3 s; then the pen’s tip was placed approximately 2 cm in 
front of both nostrils (Kobal et al., 1996). Testing was performed 
bilaterally. It involved tests for odor threshold, discrimination, 
and identification (duration of testing was approximately 30 min). 
Odor thresholds for PEA were assessed using a single-staircase, 
three-alternative forced-choice procedure. Sixteen dilutions were 
prepared in a geometric series starting from pure 4% PEA (dilution 
ratio 1:2 in propylene glycol) (Croy et al., 2009). Three pens were 
presented in a randomized order, with two containing the solvent 
and the third the odorant at a certain dilution. The subject’s task 
was to identify the odor-containing pen. Reversal of the staircase 
was triggered when the odor was correctly identified in two suc-
cessive trials for a total of seven reversals. Threshold was defined 
as the mean of the last four staircase reversal points. Subjects’ 
scores ranged between 1 and 16. In the odor discrimination task, 
triplets of pens were presented in a randomized order, with two 
containing the same odorant and the third, a different odorant. 
Using a three-alternative forced-choice technique, subjects had 
to determine which of three odor-containing pens smelled dif-
ferently. A total of 16 triplets were tested. When measuring odor 
thresholds and odor discrimination, subjects were blindfolded to 
prevent visual identification of some of the odorant-containing 
pens. Odor identification was assessed by means of 16 common 
odors. Using a multiple forced-choice design, identification of 
individual odors was performed using a list of four descriptors. 
Again, the subjects’ scores ranged from 0 to 16 (for details see 
Hummel et al., 2007).
Results of the three subtests were presented as a compos-
ite “TDI score” (range 1–48) which was the sum of the results 
obtained for threshold, discrimination, and identification meas-
ures. Using this measure, olfactory abilities can be classified in 
terms of functional anosmia (<16), hyposmia, and normosmia 
(Hummel et al., 2007).
fMri activation task
We used a two-factorial design with one between-subject factor, 
“group” (patients vs. controls), and one within-subject factor, 
“odor”. Each subject participated in two sessions with two very 
common, but hedonically very different olfactory stimuli (phe-
nyl ethylalcohol, PEA, a pleasant rose-like odor; hydrogen sulfide, 
H
2
S, the unpleasant smell of rotten eggs) which were presented 
simultaneously to the right and left nostril. Odors were presented 
intranasally (inner diameter of the Teflon™ tubing 4 mm) using 
a Burghart OM6b olfactometer (Burghart, Wedel, Germany). To 
avoid mechanical stimulation the odor pulses were embedded in 
a constant flow of odorless, humidified air. Stimulus pulses had a 
duration of 1 s, the interval between stimuli was 2 s; total flow was 
8 l/min with stimuli being presented to both nostrils. Stimulation 
was administered in blocks of 10 events (i.e., over 28 s) followed 
by a rest period of 32 s without stimulation. For each condition a 
session consisted of six stimulation periods each followed by a rest 
period yielding a duration of approximately 6 min.
fMri – data acquisition
Scanning was performed on a 1.5 T Avanto Scanner (Siemens, 
Erlangen, Germany) using a standard eight-channel head coil. 
During each of the three sessions, 130 axial echo planar imag-
ing (EPI) scans were acquired during each session including six 
dummy scans. Scan parameters were: number of slices: 35; slice 
thickness: 3 mm; interslice gap 0.3 mm; matrix size: 64 × 64; field 
of view: 192 mm; echo time (TE): 35 ms; repetition time (TR): 3 s. 
Slices were aligned parallel to the line between the anterior and 
the posterior commissure and were set to cover all of the brain 
and the upper part of the cerebellum. After the experimental ses-
sion structural T1-weighted images were obtained using a magnet 
prepared rapid gradient echo (MP-RAGE) sequence at a resolution 
of 1 × 1 × 1 mm.
data analysis
The fMRI data analysis was done using Statistical Parametric 
Mapping 5 (SPM5, www.fil.ion.ucl.ac.uk/spm/). Pre-processing 
included realignment, slice timing, normalization to a standard 
EPI template, and smoothing with a 12-mm Gaussian kernel. 
Re-sampled voxel size (after normalization) was 3 × 3 × 3 mm. 
For the first level model we convolved the onset of each single 
stimulation event as a stick function with the standard canoni-
cal hemodynamic response function used in SPM5. Rest periods 
were not explicitly modeled for. The rationale for this procedure 
(instead of modeling the whole stimulation period in an epoch 
related manner) was that detection power can be improved by such 
a model (Mechelli et al., 2003). Parameter images for the contrast 
“stimulation > (unmodeled) baseline” were generated for each 
subject and were then subjected to a second-level random effects 
analyses using (1) one-sample t-tests for testing main effects of 
stimulation in each group and each condition, (2) an independent 
sample t-test for between-group comparisons in each condition and 
(3) a 2 × 2 factorial design with group as a between-subject and 
type of stimulation as a within-subject factor in order to test for 
interactions between-group membership and type of stimulation. 
Global normalization was performed by including subjects’ global 
activation level into the models as a covariate (ANCOVA). In order 
to provide a descriptive overview over the activation pattern of 
each group in each condition, we provide results of the one-sample 
t-tests with a threshold of P < 0.015, uncorrected for the patient 
group and of P < 0.005, uncorrected for the patient group (yield-
ing comparable T thresholds for the given sample sizes). We then 
specifically tested for main effects of each stimulation paradigm in 
each group (one-sample t-tests), for group differences (two-sample 
t-tests) and for group × paradigm interactions (factorial design) in 
anatomical regions known to be relevant to olfactory processing 
(amygdala, thalamus, hippocampus Gottfried, 2006), and known to 
differentiate between Parkinson patients and control subjects (cau-
date, nucleus accumbens, anterior cingulate cortex, inferior frontal 
gyrus, Westermann et al., 2008). Masks for these regions of interest 
were generated using the Harvard-Oxford subcortical and cortical 
structural atlases distributed with FSL (FMRIB Analysis Group, 
University of Oxford, UK) with a population probability threshold 
of 50%. For the ROI analyses, only results with a P (family wise 
error, FWE-corrected for multiple comparisons across the search 
volumes [i.e., small volume corrected]) < 0.05 are reported.
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Patients
In contrast, patients did not show significant activations of the 
amydalae, hippocampi, and the thalamus. Instead the main foci of 
activation were in the striatum (caudate head), the superior medial 
prefrontal cortex, the anterior cingulate cortex, and lateral prefron-
tal cortices including the inferior frontal gyrus. In the ROI analysis, 
significantly less activation in patients compared to controls was 
observed in the right amygdala and in the right thalamus whereas 
significantly higher activation was found in the left inferior frontal 
gyrus, pars triangularis (Figure 1B; Table 2).
activation with the sMell of rotten eggs (h2s)
Controls
During stimulation with H
2
S the main foci of activation were in the 
left hippocampus (activation maximum on whole brain level) and 
bilaterally in the amygdalae. Additionally, there was a significant 
positive BOLD signal in the left NAcc (Figure 1C).
Patients
In patients there were also significant activations in the left hip-
pocampus and amygdala, whereas in the right amygdala activity 
was significantly reduced in comparison to the control group. There 
results
PsychoPhysical olfactory function
Parkinson’s disease patients presented with significantly impaired 
olfactory function (TDI mean, 19.3; range, 11–31.5) compared to 
normal controls (TDI mean, 33.9; range, 25.25–38.5).
ratings of odor stiMuli Presented during fMri scans
Idiopathic Parkinson’s disease patients rated the stimuli as less 
intense while they rated both stimuli as more pleasant, whereas 
this tended to be the other way around for controls (interaction 
“group” * “ratings”: P = 0.066).
activation with rose-like odor
Controls
Rose-like odor stimulation in the control subjects yielded wide-
spread activation of both subcortical and cortical areas largely 
consistent with previous studies on olfactory activation (Table 1). 
These included bilateral thalamus, amygdalae, hippocampi, mid-
brain, basal ganglia, and insular regions, as well as prefrontal and 
temporolateral regions. There was significant activation in all pre-
defined regions of interest except right NAcc and left inferior frontal 
gyrus, pars triangularis (Figure 1A).
FIgure 1 | Brain activation found in controls and patients. In the upper part 
results are shown for the pleasant rose odor, in the lower part results for the 
unpleasant H2S are shown. For A and B, sections are at MNI coordinates x = 0, 
y = 0, z = 0. (A) Control group – positive BOLD responses to PEA stimulation 
(threshold T = 3.7, P = 0.015, uncorrected); (B) PD patients – positive BOLD 
responses to PEA stimulation (threshold T = 3.7, P = 0.005, uncorrected); 
(C) Control group – positive BOLD responses to hydrogen sulfate stimulation 
(threshold T = 3.7, P = 0.015, uncorrected), sections at MNI coordinates x = −18, 
y = −15, z = −12 (global peak voxel activation in the left hippocampus); (D) PD 
patients – positive BOLD responses to hydrogen sulfate stimulation (threshold 
T = 3.7, P = 0.015, uncorrected), sections at MNI coordinates x = −30, y = −12, 
z = −30 (global peak voxel activation in the left fusiform gyrus).
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difference in odor processing between PD patients and healthy 
controls depending on the affective tone of the presented odors. 
When applying a pleasant odor, brain regions were activated in 
both groups that are typically involved in olfactory processing 
(amygdala, hippocampus, thalamus) (Gottfried, 2006), but con-
sistent with the literature, there was an asymmetric (right-sided) 
reduction of activation in PD patients in the amygdala and the 
thalamus which may relate to a lack of responsiveness of amygdala 
in PD patients to emotional stimuli (Yoshimura et al., 2005). 
Conversely, patients showed consistent and strong activation in 
the ventral striatum and in prefrontal lateral areas, yielding a 
significant difference compared to the control group in the pars 
triangularis of the left inferior frontal gyrus. This finding is in 
line with the assumption of an upregulation of dopaminergic 
responses to pleasant odor in PD patients. By introducing an 
unpleasant stimulus in our experimental design we are able to 
show that the effect in these dopaminergic areas depends criti-
cally on the hedonic value of the odor. For the unpleasant stimuli 
there were decreases in ventral striatal activations and there were 
no increases of activation in prefrontal lateral regions. Again, 
as for PEA stimulation, there was reduced activity in the right 
amygdalo–hippocampal complex.
Table 1 | Single group analyses.
Brain region MNI coordinates N T P
 x y z   
PEA coNTrolS
Left middle temporal gyrus −57 −57 15 8526 10.67 <0.001
Right middle frontal gyrus 54 12 48 123 6.12 <0.001
Right inferior temporal gyrus 45 3 −36 57 6.04 <0.001
Right superior temporal gyrus 42 −42 6 19 6.03 <0.001
Left paracentral  −9 −39 72 134 5.60 <0.001
Right middle orbitofrontal cortex 33 51 −6 191 5.49 <0.001
Right middle cingulate gyrus 3 −15 39 50 5.27 <0.001
Left posterior cingulate gyrus −6 −45 21 38 5.26 <0.001
Left superior frontal gyrus −27 57 21 39 5.16 <0.001
Left postcentral gyrus −39 −39 66 9 4.80 <0.001
Right precuneus 6 −39 54 29 4.78 <0.001
Left precentral gyrus −15 −27 60 13 4.47 <0.001
Left middle frontal gyrus −42 51 0 10 4.32 0.001
Left middle cingulate gyrus 3 12 42 9 4.32 0.001
PATIENTS
Right precentral gyrus 24 −30 72 89 21.50 <0.001
Left postcentral gyrus −24 −42 42 142 15.90 <0.001
Left superior frontal gyrus −15 48 39 82 13.42 <0.001
 −27 −9 51 66 13.30 <0.001
 −6 −3 51 563 12.11 <0.001
Right superior occipital gyrus 24 −84 18 256 11.04 <0.001
 48 −39 27 44 10.67 <0.001
Right middle frontal gyrus 45 21 33 53 10.04 <0.001
Right fusiform gyrus 30 −3 −36 30 9.96 <0.001
Left anterior cingulate gyrus −3 48 15 26 9.96 <0.001
Right caudate 6 12 −3 33 9.76 <0.001
 12 −48 75 18 9.66 <0.001
Brain region MNI coordinates N T P
 x y z   
 −42 −30 60 134 9.15 <0.001
 45 −24 51 34 9.05 <0.001
Left middle occipital gyrus −45 −84 18 26 8.75 <0.001
Left superior occipital gyrus −15 −78 42 71 8.40 <0.001
Right superior temporal pole 45 15 −21 9 8.29 <0.001
Right rolandic operculum 51 −18 15 12 8.18 <0.001
Right superior parietal gyrus 21 −54 51 26 7.81 <0.001
Left fusiform gyrus −30 −9 −33 34 7.45 <0.001
 33 24 −12 22 7.44 <0.001
Right inferior frontal gyrus 45 27 12 17 6.70 <0.001
Left superior temporal pole −51 12 −12 15 6.46 <0.001
Left precentral gyrus −45 3 30 10 6.03 <0.001
H2S coNTrolS
Left hippocampus −18 −15 −12 71 9.80 0.004
Right rolandic operculum 60 −18 15 186 7.24 <0.001
Right posterior cingulate gyrus  9 −42 12 55 5.90 <0.001
Right middle temporal gyrus 66 −6 −12 18 5.88 <0.001
Left fusiform gyrus −33 −72 −15 19 5.07 <0.001
Left superior frontal gyrus 0 −12 48 16 5.05 <0.001
Right postcentral gyrus 51 −18 57 9 4.44 0.001
PATIENTS
Left fusiform gyrus −30 −12 −30 37 11.16 <0.001
Right inferior occipital gyrus 51 −72 −15 32 8.45 <0.001
Left parahippocampal gyrus −12 3 −18 16 7.57 <0.001
Left angular gyrus −36 −69 42 71 7.30 <0.001
Right middle temporal pole 24 12 −39 17 6.74 <0.001
Left parahippocampal gyrus 0 −18 −30 10 5.47 0.001
Right inferior temporal gyrus 57 −33 −18 9 4.74 0.002
Right putamen 21 15 −6 25 4.72 0.002
was reduced activity (compared to baseline) during stimulation 
bilaterally in the caudate head. Compared to the control group, 
activity both in the caudate heads and in the NAcc was lower in 
the patient than in the control group (Figure 1D).
Interactions
There were significant group × stimulation type interactions in the 
striatum (caudate heads bilaterally and left NAcc) and in the left infe-
rior frontal gyrus, pars triangularis. In the striatum (Figure 2A shows 
the results for the left caudate head as an example) controls did not 
show differential responses to the two stimulus types, whereas there 
was a highly significant difference in the control group with activation 
during stimulation with the pleasant odor and deactivation during 
stimulation with the unpleasant odor. In the left inferior frontal gyrus 
the significant interaction resulted from a highly positive response to 
the pleasant odor in the patients group which was not present for the 
unpleasant odor and for both odors in the control group (Figure 2).
Discussion
In the present study we compared the effects of pleasant (PEA) 
and unpleasant (H
2
S) olfactory stimulation on brain activity in 
patients with PD and healthy controls. We observed a striking 
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recognition or a valence judgment (Royet et al., 2001). In the present 
study we used only two odors which did not sufficiently allow us to 
assess activation in relation to graded judgments across the entire 
scale of possible ratings. We also did not manipulate task demands 
during fMRI scanning. However, in our study the combination of 
fMRI data and ratings suggests that the different patterns of activa-
tion in PD patients and controls were related to differences in the 
evaluation of intensity and valence. Hyposmic PD patients rated the 
two stimuli as less intense, but also as more pleasant, whereas this 
tended to be the other way around for controls. This is in line with 
the stronger activation of the ventral striatum and the left inferior 
frontal cortex in PD patients. In contrast, following exposure to H
2
S 
controls showed reduced activation of the ventral striatum. In con-
trols, a significant bilateral activation in the amygdalo–hippocampal 
complex was observed which supports the results of Anderson et al. 
(2003) (but see also Winston et al., 2005). They found amygdala 
activation to be strongly associated with, the intensity of odors, 
which is in line with the results of our study.
Together with the behavioral results, these findings suggest 
that there is a dissociation of intensity and valence processing and 
that both components are differentially affected in hyposmic PD 
patients. While reduced intensity perception might be reflected by 
reduced activation of primary relay structures of the central nerv-
ous olfaction system (such as the amygdala), changes in valence 
perception might be attributed to changes in activation of the ven-
tral striatum and left prefrontal areas.
In a series of studies Royet et al. (1999, 2001, 2003) have shown 
that different olfactory tasks correspond with selective activation of 
different brain areas; depending on the type of olfactory task, aspects 
of odor processing were lateralized. A greater right-sided than left-
sided activity in the orbitofrontal cortex (OFC) was observed during 
exposure to odorants with strong affective valence under a familiar-
ity judgment task (Zald and Pardo, 1997, 2000; Royet et al., 2000). 
Left OFC activity however, was significantly higher during ratings 
of the hedonic character of odors. Therefore, the lateralization of 
activation in the OFC depended on whether the task required odor 
Table 2 | region of interest analyses.
 PeA H2S Interaction group  
    × stimulus
  Controls Patients Difference Controls Patients Difference (PP − PH) − (CH − CP)
Amygdala Left T = 6.7,  n.s. n.s. T = 4.3,  T = 4.3,  n.s. n.s.
  P = 0.001   P < 0.001 P = 0.044
 Right T = 4.4, n.s. C > P, T = 3.7,  T = 3.1,  n.s. C > P, T = 3.0,  n.s. 
  P = 0.014  P = 0.014 P = 0.015  P = 0.046
Hippocampus Left T = 8.0,  n.s. n.s. T = 4.9,  T = 5.9,  n.s. n.s. 
  P = 0.001   P < 0.001 P = 0.045
 Right T = 4.8,  n.s. n.s. n.s. n.s. C > P, T = 3.5,  n.s. 
  P = 0.016     P = 0.036
Thalamus Left T = 8.1,  n.s. n.s. n.s. n.s. n.s. n.s. 
  P = 0.001
 Right T = 9.4,  n.s. C > P, T = 4.0,  n.s. n.s. n.s. n.s. 
  P < 0.001  P = 0.028
Caudate Left T = 4.7,  n.s. n.s. n.s. T = −3.3,  C > P, T = 3.7, T = 4.2, P = 0.003 
  P = 0.019    P = 0.015 P = 0.024 (Caudate head)
 Right T = 5.5,  T = 9.8,   n.s. n.s. T = −3.4,  C > P, T = 3.8,  T = 3.3, P = 0.032 
  P = 0.008 P = 0.019   P = 0.015 P = 0.019 (Caudate head)
NAcc Left T = 3.2,  T = 4.6, n.s. T = 3.2,  n.s. C > P, T = 3.2,  T = 2.7, P = 0.016 
  P = 0.026 P = 0.021  P = 0.005  P = 0.013
 Right n.s. T = 9.7,  n.s. n.s. n.s. C > P, T = 2.5,  n.s. 
   P = 0.001    P = 0.046
ACC  T = 4.9,  T = 10.11,  n.s. n.s. n.s. n.s. n.s. 
  P = 0.038 P = 0.013
Inferior frontal Left n.s. T = 4.7,  P > C, T = 3.2, n.s. n.s. n.s. T = 3.4, P = 0.007
gyrus, pars triangularis   P = 0.038 P = 0.026
 Right T = 4.4,  T = 5.2,  n.s. n.s. n.s. n.s. n.s. 
  P = 0.008 P = 0.024
Inferior frontal Left T = 3.6,  n.s. n.s. n.s. n.s. n.s. T = 2.8, P = 0.025 
  P = 0.038
gyrus, pars opercularis
 Right T = 3.5,  n.s. n.s. n.s. n.s. n.s. n.s. 
  P = 0.035
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An important difference between the present study and previous 
work by Westermann et al. (2008) relates to the side of stimula-
tion. However, although Westermann et al. stimulated one nostril 
only, while in our study both nostrils were stimulated, both studies 
revealed lateralized activation in response to the odorous stimuli, 
indicating that these side differences might be a specific finding in 
PD patients. On the other hand, the differences in stimulation may 
help to explain other differences between activated areas found in 
the two studies.
The study is partly limited by the relatively small number of 
investigated subjects, which calls for studies in larger groups of 
patients. Another weakness of the study was the missing assess-
ment of dementia. However, none of the patients appeared to be 
suffering from dementia, as all of them were able to perform the 
required tasks – quite demanding tasks for the psychophysical 
measurements of olfactory function, which should have unveiled 
the presence of major cognitive deficits. In addition, while possible 
differences between patients and controls in terms of dementia can-
not be excluded, it appears unlikely that dementia would produce 
lateralized differences in the processing of odors.
To summarize, alterations in olfactory processing in PD appear 
to produce a distinct pattern of cortical and subcortical activation 
compared to healthy individuals. This may partly explain why 
the experience – defined in terms of two primary dimensions of 
odors, intensity and valence – may vary between PD patients and 
healthy controls.
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FIgure 2 | Differential brain activation in controls and patients. 
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gyrus, pars triangularis). MNI coordinates of peak voxel: x = −54, y = 30, z=3. 
(C,D) Parameter estimates separately for patients and controls, both for the 
pleasant PEA and the unpleasant H2S, corresponding to A and B, respectively.
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